4
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Quantitative Bone Scintigraphy in Patients with Prostatic Carcinoma Treated with LH-RH Analogues

, , &
Pages 29-32 | Received 20 Dec 1994, Accepted 16 Feb 1995, Published online: 15 Feb 2010

REFERENCES

  • Brawn PN, Speights VOThe dedifferentiation of metastatic prostate carcinomaBr J Cancer 1989; 59: 85–88.
  • Chybowski FM, Larson Keller JJ, Bergstralh EJ, Oesterling JEPredicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parametersJ Urol 1991; 145: 313–318.
  • Crawford EDHormonal therapy of prostatic carcinoma. Defining the challengeCancer 1990; 66: 1035–1038.
  • Grayhack JT, Keeler TC, Kozlowski JMCarcinoma of the prostate. Hormonal therapyCancer 1987; 60: 589–601.
  • Hetherington JW, Siddall JK, Cooper EHContribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancerEur Urol 1988; 14: 1–5.
  • Huggins C, Hodges CVStudies on prostatic cancer. 1. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostateCancer Res 1941; 1: 293–297.
  • Matzkin H, Perito PE, Soloway MSPrognostic factors in metastatic prostate cancerCancer 1993; 72: 3788–3792.
  • Smith JAJrNew methods of endocrine management of prostatic cancerJ Urol 1987; 137: 1–10.
  • Snedecor GW, Cochran WGStatistical methods 7th ed.Iowa State University PressAmes, Iowa1980.
  • Soloway MSThe importance of prognostic factors in advanced prostate cancerCancer 1990; 66: 1017–1021.
  • Sundkvist GMG, Ahlgren L, Lilja B, Mattsson S, Abrahamsson PA, Wadström LBRepeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomyEur J Nucl Med 1988; 14: 203–206.
  • Sundkvist GMG, Ahlgren L, Lilja B, Mattsson S, Abrahamsson PADynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomyEur J Nucl Med 1990; 16: 671–676.
  • Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SAdditional information from quantitative 24-hour 99mTc-MDP bone scintigraphy in patients with prostatic carcinomaActa Oncol 1991; 30: 635–639.
  • Sundkvist GMGQuantitative bone scintigraphy. A study in patients with prostatic carcinoma1991 Thesis, Malmö..
  • Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SQuantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinomaNucl Med 1992; 31: 178–181.
  • Sundkvist GMG, Ahlgren L, Lilja B, Mattsson SQuantitative bone scintigraphy in prostatic carcinoma — long-term response to treatmentNucl Med 1993; 32: 231–235.
  • Wang MC, Valenzuela LA, Murphy GP, Chu TMPurification of a human prostate specific antigenInvest Urol 1979; 17: 159–163.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.